The synthesis of l-[llC]-D,L-homocysteine thiolactone, a potential tracer for PET imaging of ischemic heart regions, is described. The labelling is achieved by reaction o f [llC]carbon dioxide with 0-1 ithiated S-(tetrahydropyran-Z-y1)3-thiopropyl isonitri le. Deprotection o f the mercapto group and
Preparation of 4-[11C]methylmetaraminol, a potential PET tracer for assessment of myocardial sympathetic innervation
✍ Scribed by Oliver Langer; Tobias Forngren; Johan Sandell; Frédéric Dollé; Bengt Långström; Kjell Någren; Christer Halldin
- Publisher
- John Wiley and Sons
- Year
- 2002
- Tongue
- French
- Weight
- 114 KB
- Volume
- 46
- Category
- Article
- ISSN
- 0022-2135
- DOI
- 10.1002/jlcr.642
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
The false adrenergic neurotransmitter [^11^C]meta‐hydroxyephedrine ([^11^C]HED) is currently the PET tracer of choice for assessment of myocardial sympathetic innervation. The molecule is metabolised in the 4‐position of the aromatic ring. The resulting radiolabelled metabolites need to be measured in order to obtain an arterial input function. Our aim was the development of a PET tracer with an increased metabolic stability relative to [^11^C]HED. We selected 4‐methylmetaraminol as a candidate molecule for radiolabelling with ^11^C (t~1/2~ 20.4 min). Our radiosynthetic approach towards 4‐[^11^C]methylmetaraminol involved a palladium‐catalyzed cross‐coupling reaction of a protected 4‐trimethylstannyl derivative of metaraminol with [^11^C]methyl iodide followed by removal of the protective groups. 4‐[^11^C]methylmetaraminol was obtained in a final decay‐corrected radiochemical yield of 20–25% within a synthesis time of 60–80 min. The specific radioactivity at the end of the synthesis ranged from 18–37 to GBq/μmol. The unlabelled reference molecule, 4‐methylmetaraminol, was prepared in a 5‐step synthesis starting from metaraminol. A biological evaluation of 4‐[^11^C]methylmetaraminol is in progress and the results will be reported elsewhere. Copyright © 2002 John Wiley & Sons, Ltd.
📜 SIMILAR VOLUMES
A novel selective and partial agonist S21007 (IC% =InM), for 5HT3 receptor studies in positron emission tomography, has been labelled with ("Cjbenzyl iodide in 40-50% radiochemical yield and 200-700mCilpmol in 60 min synthesis time.
## Abstract Synthesis of [__O__‐methyl‐^11^C]‐4‐(1,3‐dimethoxy‐2‐propylamino)‐2,7‐dimethyl‐8‐(2,4‐dichlorophenyl)[1,5‐a]pyrazolo‐1,3,5‐triazine ([^11^C]DMP696), a highly selective CRF~1~ antagonist has been achieved. The total time required for the synthesis of [^11^C]DMP696 is 30 min from EOB usin